| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 江苏蓝丰生物化工股份有限公司是一家主要从事杀菌剂、杀虫剂、除草剂等农药原药、制剂和精细化工中间体的研发、生产、销售的公司.公司主要产品包括多菌灵、甲基硫菌灵、苯菌灵、环嗪酮、吡唑草胺、精胺、氯甲酸甲酯和氯甲酸乙酯等.公司的杀菌剂产品甲基硫菌灵、多菌灵、除草剂产品环嗪酮的生产工艺达到世界先进水平.根据中国农药工业协会2010年提供的资料,公司在国内率先研发和生产甲基硫菌灵,是国内最大的甲基硫菌灵生产企业之一.截至2010年,公司是国内多菌灵原药的主要供应商,产能位于全国三甲,也是国内为数不多的可生产精胺(杀虫剂甲胺磷、乙酰甲胺磷的中间体)的企业,生产能力位于全国前列,公司也是国内环嗪酮的攻关单位,是全国该产品的主要供应商,产品质量可以与杜邦公司同类产品相媲美.公司产品远销国外,出口范围覆盖北美、南美、欧洲、亚洲等35个国家和地区。 | ||||||||||||||||||||||||
| Main Business | 主要从事农药原药及剂型、光伏电池及组件的研发、生产和销售业务。 | ||||||||||||||||||||||||
| Legal Representative | 李质磊 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 唐海军 | ||||||||||||||||||||||||
| Solicitors | 北京市万商天勤律师事务所 | ||||||||||||||||||||||||
| Auditors | 北京中证天通会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0516-88920479 | ||||||||||||||||||||||||
| Fax No | 0516－88923712 | ||||||||||||||||||||||||
| Website | www.jslanfeng.com | ||||||||||||||||||||||||
| lfshdmb@jslanfeng.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 03/12/2010 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.891 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 0.067 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.132B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |